The study that 'should basically end any scientific debate' about masks
A massive randomized trial on how well masks hold up against symptomatic COVID-19 infections may be one of the most crucial studies of the coronavirus pandemic because it was able to solve the tricky issue of examining mask-wearing at a community level rather than an individual one.
The study involved launching pro-mask campaigns in some Bangladeshi villages, but not others, and the authors made two key findings. First, they determined that the public health interventions nearly tripled mask usage from 13 percent to 42 percent. Secondly, they discovered — by conducting sero-surveys backed up by interviews about COVID-19 symptoms and medical history — that masks did their job and reduced symptomatic infections in the communities that were subject to the campaigns by 9.3 percent. Jason Abaluck, an economist at Yale University who helped lead the study, told The Washington Post that figure would probably be higher if masking was universal.
There were a few other key notes in the study. Surgical masks were found to be particularly effective, while the jury is still out on cloth masks. And they were more effective in people older than 50, which could be explained by a few factors, including that young people were less likely to be symptomatic either way. They also may have been less compliant when it comes to masks.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Either way, Abaluck is pretty confident about the research, arguing that it "should basically end any scientific debate about whether masks can be effective in combating [COVID-19] at the population level" and calling it "a nail in the coffin" for anti-mask arguments. Read more at The Washington Post.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The week's best photos
In Pictures Playful goslings, an exploding snowman, and more
By Anahi Valenzuela, The Week US Published
-
What is rock flour and how can it help to fight climate change?
The Explainer Glacier dust to the rescue
By Devika Rao, The Week US Published
-
Crossword: April 19, 2024
The Week's daily crossword puzzle
By The Week Staff Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published